TGF-β1在结直肠腺瘤与非肿瘤性息肉中的表达差异及其与细胞增殖的关系
TGF-β1在结直肠腺瘤与非肿瘤性息肉中
的表达差异及其与细胞增殖的关系
!"#$%&'#()*+*,*&-*./#-)!"#0&#*!1#)!(23#4!*/5*)46 #&7$#1-)*&+-)$%&'-4*/8)4(/('9:;;;<=>:=6>>?7 @A*1*'%4"-0B(&-00*C*"*+"-D#!*/75()!&(E#&+9*.(%! !&#*!1#)!(24(/(!*/4*)4#&-)E-#F(2+%&'#()66/91G" )(H#H-++#4!-()2(&4(/(!*/+%&'#&9/*!#&*//91G")(H# H-++#4!-()*)H0BIJ*)0(D*'*C%39("(:;;>>;=<
:?@6=7
K75(/(&L(GG/#&M/(FN1*'-)'"
7<==?
OP<<<;>>6<;O<7
P7"
7:;;>:@>:P<6:=<7
=Q#"*)H#&B*&!/-)'RS(/103%!TE-+!UV#!*/I22#4!(2 *+%&'-4*/!&*-)-)'G&('&*11#()(%!4(1#(2!*/4*)4#&-)
!"#5(%)!9(2$!(4C"(/170"#/*)4#!:;;;>?@P=>6=@7
<;0*C*"*+"-0W#)(BRX#C%&*D#!*/7Q*!#&*/)(H#H-+6 +#4!-()*)H!(!*/B#+(!*/#Y4-+#()2(&!*/4*)4#&7L-+ 5(/()!%1:;;;O><;P?=6P@P7
<<U(C#9IQ5"*G%-+ZSL#)!8M#!*/7$%&'-4*/!#4")-T%# *)H+%&E-E*/-)G*!-#)!S*E-)'*5%&*!-E#3#+#4!-()2(&5(6 /()4*)4#&L-+5(/()3#4!%1:;;>K;P@;6P@@7
:;;@6<;6<K
"[$;O<65>>6::0
JM6!<"
\\K>;;;;\\\\\6!<0JM6!<$
6Z>@>@<><<0JM6!<D-6@K0
JM6!<13]R0JM6!<13]RD-6@K!
^;_;?ZN0JM6!<"#';_??K!^;_;<0JM6!<0
JM6!<6!<D-6@K3K>?_>
!"##$%$&'$"&()$*+,%$--".&.#/012!<3&45(-6$73(".&-)",8"()9$77:%.7"#$%3(".&"&9.7.%2
$'(37;4$&.<33&4=.&2&$.,73-("':.7>,
a*)'V-+%-5"#)'[-()'b"*)'R-/-#!*/7L#G*&!1#)!(2Z*!"(/('9Z#(G/#c+S(+G-!*/(2J*)+%Z&(E-)4#Q
*)X"(%K>;;;;
;?-(%3'(\@?A$'("B$0(-)E#+!-'*!#!"#H-22#&#)4#-)!"##YG&#++-()(2!&*)+2(&1-)''&(F!"2*4!(&6!<0JM6!<
*)H-!+&#/*!-()+"-GF-!"4#//G&(/-2#&*!-()-)4(/(!*/*H#)(1**)H)()6)#(G/*+!-4G(/9G7C$().4-0"##YG&#+6
+-()+(20JM6!<*)HD-6@K-)>@4(/(!*/*H#)(1*!-++%#+>@)()6)#(G/*+!-4G(/9G!-++%#+<>4*+#+4(/(!*/
*H#)(4*&4-)(1*!-++%#+*)H<<)(&1*/4(/(!*/1%4(+*F#&#H#!#4!#H.9-11%)("-+!(4"#1-4*/1#!"(H70"##Y6
G&#++-()(20JM6!<13]RF*+H#!#4!#H.9-)+-!%"9.&-H-X*!-()76$-D7(-0"##YG&#++-()+(20JM6!<G&(!#-)0
JM6!<13R]*)HD-6@K-)4(/(!*/*H#)(1*!-++%#+F#&#"-'"#&!"*)-))()6)#(G/*+!-4G(/9G!-++%#+!^;7
;?7RG(+-!-E#+-')-2-4*)!4(&&#/*!-()F*+2(%)H.#!F##)ZN*)H!"##YG&#++-()H#'&##+(20JM6!<-)4(/(!*/
*H#)(1*!-++%#+"#';_??K!^;_;<79.&'7D-".&0JM6!<-+4(&&#/*!#HF-!"4#//G&(/-2#&*!-()*4!-E-!9-)
4(/(!*/*H#)(1*!-++%#+7N!4*).#()#(2!"#-1G(&!*)!1(/#4%/#1#4"*)-+1+(2H-22#&#)!1*/-')*)!!#)H#)49!"*!
!"##YG&#++-()(20JM6!<-+"-'"#&-)4(/(!*/*H#)(1*!"*)-))()6)#(
G/*+!-4G(/9G7 P>>:;;@<:@
!"#$%&'(!"#$#%&'()$)*&+#,)-#+.+&#/$)0(1'/#$2/3%)+04#%,1+
55%#6(74)'(#%.!891.:;"&$$/%#$14&%)(1#+
!!8
<
=>?
@
!83%)+0.
4#%,1+55%#6(74)'(#%.!83AB.!83
AB.!83
AB.!891.:;3 AB.!88
!8
C8!8DD<E ?==@E;
?F=@:8FG
;;F<CE@:8 ?8?8?
@:8?8?8
?888
@8
=>F
",8
C?!8
C?C8!H.I3
AB.!891.:;H IH
II
JH8
C?C?!3AB.!8,K-LJM"IN
-J33
AB.!88
EO.L""3A"LLAL""L3"AL"L3AALA" 3AA3ALLL"A.@O?EO."A3A"LALA"3A"A" 33A"LALAL33LLLL3"LLA.@O@EO."L"LA "3"L"AA"L""AALALA"""3AAL3L""LL.@OP
QAB8
C@!8
C@C8!3AB.!8#
=R?E>8?EG
E=>?SE=>@$=
8?
@R?T?G@U
FG:UUS:U
UU91.:;I
MI%#$14&%)(1#+M+*&VE8 ===>
8
C@C?!PQAB,K-L#
=
R?E>8?EGE=>?SE=>@$ =
8?@R
?T?G@UFG:U
US:UUU8
CF!HIHH8=C=W
HXH/&)%,)+
?
!!?
C8!3AB.!8,K-L3 AB.!8N
3
AB.!8!
S=C=E!
R=C=E3AB.!8,K-L3AB.!88
D
@@?==:8?:
!"#$%&!!'()*! #$%&!!#$%&!!'()*+
,,,,,,+,,,,,, !!!-!--!-!--
./0.!0!-0/1!- ./!2!34-!4!/.- !.!43-042-
050"67&/4898 91
50/:.5!4!!5!0: .5-42!5;.:25-3/.5./ :25./89"
<-5-3"
=-5-!.
5."89#$%&!!> ?@AB'AC89
#$%&!!#$
D
-5334"=-5-!.
""#
$%&!#
$%&!3#
$%&!!# $%&!!2 3
#
$%&!!# $%&!!# $%&!!6 7&/4E
)*8
F&
)*898
9!
G.#
$%&!!8 9#
$%&!!#$%&!!#
$%&!!# $%&!!# $%&!("#$%&!!
/
"
""!
HHH!11/!
420;/&0;;H 0HH
H0--!./!3
1&/!H
.HH!
11;!0/021&03!H
2I7JKLBM'8EA'N@BOP@BQR*H(MS@MTLBACKTMB'7CQ
QBMULRTAVLMB&N@LA!7C?BMKLAL@VACV@BHW7VBMKV(@K#@VR0
--!3022!!H
3X7MCPFMCQYYZRACQ%@LASH#$%N@LA!@[?B@KK7MC AC\ACQ7MQ@C@K7K7CVMSMB@VLASVACV@BL7KK]@HIMBS\OFA&
LBM@CL@BMS0--0;.21/H
/WALK]KR7LAWWALK]^AJ76EAL@W@LASHEMUC&B@Q]SA& L7MCMT#$%&N@LAB@V@?LMBK7CR]'ACVMSMB@VLASVACV@B7'&
?S7VAL7MCKTMBVACV@B\@_@SM?'@CLHPBOVACV@B!111;-!& 0!12&0-3H
0--/&-/&00
-2.0--/!0/